Buckanovich et al. (27) found that EGFL6 was abundantly expressed in breast cancer, lung cancer, meningioma, melanoma, and ovarian cancers compared with normal tissues, and proposed that EGFL6 was a tumor blood vessel protein and a biological marker of ovarian cancer. This evidence concerns the gene EGFL6 and lung carcinoma.